XML 79 R68.htm IDEA: XBRL DOCUMENT v2.4.0.6
Related party transactions (Details Textual) (USD $)
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Related Party Transaction [Line Items]      
Dividends received from related party $ 0 $ 0 $ 110,000,000
Kirin-Amgen [Member]
     
Related Party Transaction [Line Items]      
Ownership interest (in percent) in related party 50.00% 50.00% 50.00%
Dividends received from related party     110,000,000
Payments that may be received upon the achievement of various substantive success-based development and regulatory approval milestones 125,000,000    
Kirin-Amgen [Member] | Accrued liabilities[ Member]
     
Related Party Transaction [Line Items]      
Amount owned to related party 75,000,000 62,000,000  
Kirin-Amgen [Member] | Noncurrent other assets [Member]
     
Related Party Transaction [Line Items]      
Approximate carrying value of the company's equity method investment net of dividends received 400,000,000 400,000,000  
Kirin-Amgen [Member] | Selling, General and Administrative [Member]
     
Related Party Transaction [Line Items]      
Company's share of profits of related party 47,000,000 71,000,000 72,000,000
Kirin-Amgen [Member] | Other revenues [Member]
     
Related Party Transaction [Line Items]      
Revenues earned by Amgen from related party 130,000,000 96,000,000 102,000,000
Kirin-Amgen [Member] | Research and development [Member]
     
Related Party Transaction [Line Items]      
Cost recoveries by Amgen from related party 85,000,000 88,000,000 96,000,000
Kirin-Amgen [Member] | Cost of sales excludes amortization of certain acquired intangible assets [Member]
     
Related Party Transaction [Line Items]      
Royalties earned by related party from Amgen $ 298,000,000 $ 322,000,000 $ 327,000,000